GSDMA |
Gastrointestinal tract, skin, esophagus, stomach and mammary gland |
Programmed cell death |
Not known |
Alopecia and Infammatory disorders |
Saeki et al., 2000, 2007; Zhou et al., 2012; Soderman et al., 2015
|
GSDMB |
Gastrointestinal tract, lung, lymphocytes, liver, colon, esophagus and cancer cells |
Pyroptosis |
Caspase-1, -3, -4, -6, -7 and granzyme A |
Asthma, type I diabetes, ankylosing spondylitis, inflammatory disorders and cancer |
Das et al., 2016; Chao et al., 2017; Chen Q. et al., 2019; Zhou et al., 2020
|
GSDMC |
Gastrointestinal tract, trachea, spleen, esophagus, stomach and cancer cells |
Pyroptosis |
Caspase-8 |
Cancer |
Kusumaningrum et al., 2018; Hou et al., 2020
|
GSDMD |
Skin, esophagus, stomach, immune cells and cancer cells |
Pyroptosis, inflammation, and host defense |
Caspase-1, -4, -5, -8, -11, cathepsin G and neutrophil elastase |
Infammatory disorders and cancer |
Katoh and Katoh, 2004b; Sarhan et al., 2018; Burgener et al., 2019; Liu et al., 2020
|
GSDME |
Brain, heart, kidney, placenta and cancer cells |
Pyroptosis and antitumor immunity |
Caspase-3 and granzyme B |
Deafness and cancer |
Van Laer et al., 1998; Rogers et al., 2017; Zhang et al., 2020
|
PJVK (DFNB59) |
Auditory system |
Not known |
Not known |
Deafness |
Mujtaba et al., 2012; Liu et al., 2013
|